Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Daiichi Sankyo
Moodys
Harvard Business School
Chubb
UBS
Healthtrust
Merck

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SECRETIN SYNTHETIC HUMAN

« Back to Dashboard

Clinical Trials for Secretin Synthetic Human

Trial ID Title Status Sponsor Phase Summary
NCT00036231 Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction Terminated Repligen Corporation Phase 3 The purpose of the study is to determine the effect of multiple doses of secretin on autism.
NCT00036244 Synthetic Human Secretin in Children With Autism Completed Repligen Corporation Phase 3 The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.
NCT00065962 Secretin for the Treatment of Autism Completed National Institute on Deafness and Other Communication Disorders (NIDCD) Phase 3 Many drugs used to treat autism target specific symptoms, such as hyperactivity and aggressiveness. Few drugs target the core autistic symptoms of impaired social interaction and communication. This study will evaluate two forms of the drug secretin for the treatment of core autistic symptoms.
NCT00065962 Secretin for the Treatment of Autism Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 3 Many drugs used to treat autism target specific symptoms, such as hyperactivity and aggressiveness. Few drugs target the core autistic symptoms of impaired social interaction and communication. This study will evaluate two forms of the drug secretin for the treatment of core autistic symptoms.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Secretin Synthetic Human

Condition Name

Condition Name for Secretin Synthetic Human
Intervention Trials
Autism 3
Chronic Pancreatitis 2
Intraductal Papillary Mucinous Neoplasms 1
Acute Recurrent Pancreatitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Secretin Synthetic Human
Intervention Trials
Autistic Disorder 3
Pancreatitis 3
Pancreatitis, Chronic 2
Obsessive-Compulsive Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Secretin Synthetic Human

Trials by Country

Trials by Country for Secretin Synthetic Human
Location Trials
United States 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Secretin Synthetic Human
Location Trials
Massachusetts 4
Washington 2
Indiana 2
Colorado 2
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Secretin Synthetic Human

Clinical Trial Phase

Clinical Trial Phase for Secretin Synthetic Human
Clinical Trial Phase Trials
Phase 3 5
Phase 2 1
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Secretin Synthetic Human
Clinical Trial Phase Trials
Completed 5
Terminated 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Secretin Synthetic Human

Sponsor Name

Sponsor Name for Secretin Synthetic Human
Sponsor Trials
Repligen Corporation 4
Massachusetts General Hospital 3
Indiana University School of Medicine 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Secretin Synthetic Human
Sponsor Trials
Other 5
Industry 5
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Chinese Patent Office
Covington
McKinsey
US Department of Justice
Citi
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.